tiprankstipranks
Trending News
More News >
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Financial Statements

Compare
112 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently $53.74M. The company's EPS TTM is $-0.525; its P/E ratio is ―; Context Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -12.04K$ -9.27K$ 0.00$ 0.00
Operating Income$ -29.92M$ -25.07M$ -15.38M$ -10.53M$ -2.57M
EBITDA$ -29.92M$ -25.06M$ -14.83M$ -10.53M$ 0.00
Net Income$ -26.73M$ -23.96M$ -14.29M$ -7.43M$ 6.64M
Balance Sheet
Cash & Short-Term Investments$ 94.43M$ 14.45M$ 35.50M$ 49.64M$ 341.04K
Total Assets$ 98.13M$ 16.06M$ 37.97M$ 51.31M$ 467.34K
Total Debt$ 219.38K$ 0.00$ 55.08K$ 0.00$ 5.95M
Net Debt$ -94.21M$ -14.45M$ -35.44M$ -49.64M$ 5.61M
Total Liabilities$ 2.86M$ 4.19M$ 3.21M$ 3.03M$ 17.39M
Stockholders' Equity$ 95.27M$ 11.87M$ 34.76M$ 48.27M$ -16.92M
Cash Flow
Free Cash Flow$ -29.31M$ -21.05M$ -14.09M$ -9.05M$ -1.03M
Operating Cash Flow$ -14.56M$ -21.05M$ -13.55M$ -8.80M$ -1.03M
Investing Cash Flow$ -14.76M$ 0.00$ -536.84K$ -250.00K$ 0.00
Financing Cash Flow$ 109.29M$ 0.00$ -102.07K$ 58.39M$ 1.15M
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis